Madrigal pharmaceuticals – News & Updates

Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer

adminFebruary 1, 20220846 views

Synopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F.…

Positive Phase III Data Lifts Madrigal, Hopes for an Effective NASH Treatment

adminFebruary 1, 20220602 views

Synopsis : Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III…